downloads search feedback sitemap intranet webmail home
 

 
Home->ACME Laboratories->News (Press Release)

 

ACME Press Release (13-04-2008)

 

New Introduction
 

one of the top pharmaceutical companies in Bangladesh, has recently launched sustained release formulation of Tramadol HCI as Dolonil SR tablet 100mg.


Dolonil SR tablet is the first manufactured sustained release formulation of Tramadol HCI in Bangladesh. Dolonil SR tablet is a potent pain killer and is indicated in post operative pain, traumas and fractures, musculoskeletal pain, neurogenic pain, cancer pain etc.

 

DOLONIL is a centrally acting synthetic opioid analgesic with fewer side effects. DOLONIL is as effective as pethidine with reduced respiratory depression, sedation and constipation. Dolonil SR tablet minimises the dosing frequency as it requires to be taken twice daily whether immediate release formulation of Tramadol HCI requires 4-6 times daily for complete therapeutic action.


Dolonil is currently available in SR tablet, capsule and injection form. Each box of Dolonil SR tablet contains 16 tablets (2 x 8s) in blister strips and price is Tk. 14.00 per tablet only.
 


For More Information Contact:
Product Management Department
Court de la ACME
The ACME Laboratories Ltd.
Dhaka, Bangladesh.